Delivery Order SPE2DB25D3404-SPE2DB25FUPKY
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,257.43 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pharmaceuticals, with a completion date of June 9, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued on June 6, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $33,637.70 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on September 9, 2025, with a completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid...
- The Defense Logistics Agency awarded a $9,749.84 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside delivery order represents a single line item procurement from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $13,880.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 11, 2025. This non-set-aside competitive award was issued on September 10, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat autoimmune conditions and is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,226.52 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution...
- The Defense Logistics Agency awarded a $31,964.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026. The product being delivered—ENBREL, a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,276.74 for ENBREL 50 mg/mL SureClick auto-injectors on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.67 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a $52,670.24 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...